Hallucinogenic drug · misdemeanor possession
Vermont treats psilocybin as a hallucinogenic regulated drug. Unauthorized possession is punishable by up to one year in jail and a $2,000 fine.

VT legal and access quick reference
Reviewed on October 4, 2026 by iMD teamA concise, source-dated explanation of statewide law, regulated access, and the difference between state and local policy.
Laws and implementation can change quickly. This page is educational information, not legal advice.
Vermont treats psilocybin as a hallucinogenic regulated drug. Unauthorized possession is punishable by up to one year in jail and a $2,000 fine.
Vermont has no statewide personal-use, retail, dispensary, or regulated psilocybin service program.
Vermont’s prior Psychedelic Therapy Advisory Working Group recommended continued monitoring and research focused on psilocybin. In 2026, H.859 proposed a permanent-style advisory board, professional education, and a pilot concept for psilocybin-assisted therapy in serious illness, trauma, mental health, and substance-use settings. H.859 remains a proposal and did not create public access.
Vermont continued policy work around psychedelic therapy in 2026. H.859 proposed a Psychedelic Therapy Advisory Board that would review current research, monitor therapeutic programs in other states, develop education for health professionals and the public, and propose a pilot project for psilocybin-assisted therapy in end-of-life care or for people with serious illness, trauma, mental health conditions, or substance-use disorders. The bill was introduced on February 3, 2026 and referred to the House Committee on Health Care; it has not become law.
The proposal builds on Vermont’s earlier Psychedelic Therapy Advisory Working Group. That group’s final report concluded that psilocybin had the strongest research base among the psychedelics it reviewed and recommended continued monitoring of research and programs as Vermont considers future therapeutic approaches.
For Burlington, Montpelier and Rutland, this Vermont page is the appropriate quick-reference starting point because no separate municipal action was retained as a distinct local-policy guide. Local rules can change, so verify current official records.
The statewide explanation above covers Burlington, Montpelier and Rutland. A separate page appears below only where a documented municipal action adds material local context.
This page was checked against the controlling state statutes, enacted laws, agency records, and official bill histories listed below.
No. Vermont treats psilocybin as a hallucinogenic regulated drug. Unauthorized possession is punishable by up to one year in jail and a $2,000 fine. No statewide public-access program has been enacted.
No statewide public-access program has been enacted. Vermont has, however, continued studying therapeutic policy: the prior advisory group recommended continued psilocybin-focused research and monitoring, and H.859 in 2026 proposed an advisory board and a future psilocybin-assisted therapy pilot.
H.859 was introduced in February 2026 to create a Psychedelic Therapy Advisory Board, expand professional education, and develop a possible psilocybin-assisted therapy pilot for serious illness, trauma, mental health, and substance-use conditions. The proposal remains pending and has not created legal public access.
No. A local enforcement-priority policy may affect municipal enforcement, but it does not legalize commercial sale, create statewide legality, or override federal law.
The product-site link provides product-format and business-policy information. It does not change the law described on this page or establish legal access in any jurisdiction.